Draft points to consider on frailty: Evaluation instruments for baseline characterisation of clinical trial populations

  • Email
  • Help

Document details

Download document Draft points to consider on frailty: Evaluation instruments for baseline characterisation of clinical trial populations
Reference number EMA/CHMP/778709/2015
Status draft: consultation open
First published 21/12/2015
Last updated 21/12/2015
Consultation start date 21/12/2015
Consultation end date 31/05/2016
Email address for submissions geriatrics@ema.europa.eu

Summary

Older persons are large drugs consumers for a number of chronic diseases, but despite this they have often been excluded from clinical trials.